about
Cooperative interaction between ETS1 and GFI1 transcription factors in the repression of Bax gene expressionEfficacy of a novel class of RNA interference therapeutic agentsA novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.Optimization of a Genome-Wide Disordered Lentivector-Based Short Hairpin RNA Library.Viral-based modelling and correction of neurodegenerative diseases by RNA interference.Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation.Drosophila TIM binds importin α1, and acts as an adapter to transport PER to the nucleus.A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.Harnessing RNAi nanomedicine for precision therapySelectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.Activation of the mammalian immune system by siRNAs.Cancer research with non-coding RNA.Prevention of Tendon Adhesions by ERK2 Small Interfering RNAs.Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury.Special delivery: targeted therapy with small RNAs.Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.Therapeutic implications of small interfering RNA in cardiovascular diseases.A daunting task: manipulating leukocyte function with RNAi.Dendrimers for siRNA Delivery.microRNA profiling in atherosclerosis, diabetes, and migraine.Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability.Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection.Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion.Silencing and complementation of reovirus core protein mu2: functional correlations with mu2-microtubule association and differences between virus- and plasmid-derived mu2.RNAi-mediated silencing of TEL/AML1 reveals a heat-shock protein- and survivin-dependent mechanism for survival.Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer.Efficient siRNA transfection to the inner ear through the intact round window by a novel proteidic delivery technology in the chinchilla.Bioreducible polyethylenimine nanoparticles for the efficient delivery of nucleic acids.Control of HCV Replication With iMIRs, a Novel Anti-RNAi Agent.Construction of HCC-targeting artificial miRNAs using natural miRNA precursors.siRNAs targeted to Smad4 prevent renal fibrosis in vivo.TGF-β₁-siRNA delivery with nanoparticles inhibits peritoneal fibrosis.Toxicity profiling of several common RNAi-based nanomedicines: a comparative study.Cellular Delivery of siRNAs Using Bolaamphiphiles.Resistance to 6-Methylpurine is Conferred by Defective Adenine Phosphoribosyltransferase in Tetrahymena.RNAi in Respiratory DiseasesJack of many trades: Multifaceted role of neuropilins in pancreatic cancerA novel small inhibitor, LLL12, targets STAT3 in non-small cell lung cancer and
P2860
Q24292737-BEA8F97F-15A3-4CD8-98FB-042DC52B2AE4Q28482283-AE16869A-54D5-4530-BF60-1E4EEE92CFC3Q30492764-77137AB2-AF2E-4C3B-9A0B-639FBA96E630Q33506420-5B3F8748-F42C-4931-80BF-5ADC582BBF73Q34471754-2C77D71E-7188-4D67-AC42-0E89536E016AQ34622662-43082893-5C59-4DFC-955F-8449C19DA5A0Q34995114-FD1F4F12-0761-4FA2-A853-BB593E532542Q35559801-054E099B-8F30-490A-8A23-A65000F3D6B5Q35587194-C1D85AE3-9AB9-4292-8DEC-604FD9A31CFBQ35673875-1143CEF4-5889-46F9-997E-10344A6621A4Q36012200-8A4DDA3F-31D3-4D93-B0E2-0DDF71BB9159Q36307323-44EC80E7-CA96-4CE2-98ED-D69F7A2E7B87Q36628692-6C40C6A2-EBEF-4253-8F1E-95C09E08CCA9Q36656239-9BE7D0F3-01E1-4096-B8FC-B82465092E2AQ37739688-522A1DEA-20F9-4B5D-9F5C-BD9F1CCB6A7EQ37864924-C4A7286E-60B7-4F2E-82C3-0E0058707729Q37869444-86012247-C7DA-489D-A652-C662FE0DE470Q38023881-18EAD0B7-1D0B-44FA-AF16-479C9BBC7E61Q38095502-D7844244-84BF-4DC7-89C9-3E9CB6A821D5Q38166200-1916A341-24F2-48A0-A2EE-DBA51DCC2294Q38827929-627FA8C6-3E37-4E42-B315-E832A0BE48E7Q39476902-7424B965-A1BF-4AC3-B4B3-78BAEA19DB64Q39739512-BBEF95BA-C6AF-40AC-ABF4-548D35AE8231Q39876145-F7F5ED29-B972-4D91-B8BB-3F0C6FAA8C76Q40142474-20864399-B517-4C7E-A6AF-0F67E8F01228Q40210058-F6E69690-AE23-49C2-97F9-ACEE9CF030A6Q41818628-8A0A14C2-A080-47EE-8BF6-A7D8150B297BQ41845496-DFC8643A-0A57-4A27-A274-7F27C4234073Q42173310-862841B6-9FA3-41D8-8337-F8A4DF466916Q42175896-FB41F214-E28B-479D-A0AE-29CF2EB076DDQ42540974-BDF7235D-EF8F-4622-8F3C-DA93A7E29393Q42905735-7A7ACBF2-941C-46E7-B446-67BFA15967BCQ45871847-A26696CC-A770-402A-8C42-8A01FEA17949Q47570622-4255979B-ECDC-4B51-BF97-745931277B2CQ50196639-11F9B2DE-9AFF-4FFA-AEB4-53D4092BD2B9Q52640469-271B62AF-6D02-4364-9170-9DBE55C9EE97Q58061971-730DBDA5-8369-4C84-B7F7-76C0E91ADB83Q58738114-5DFE2277-1F6D-4BC5-8F90-AC145C442117Q58800840-24FEA587-16FE-4FD6-82DB-1543B6863349
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
RNA interference in biology and disease
@ast
RNA interference in biology and disease
@en
type
label
RNA interference in biology and disease
@ast
RNA interference in biology and disease
@en
prefLabel
RNA interference in biology and disease
@ast
RNA interference in biology and disease
@en
P2860
P1433
P1476
RNA interference in biology and disease
@en
P2093
Carol A Sledz
P2860
P304
P356
10.1182/BLOOD-2004-12-4643
P407
P577
2005-04-12T00:00:00Z